AI summary · may contain errors
High-throughput base editor tiling in lung cancer cells identifies SHP2 gain-of-function mutations linked to resistance against migoprotafib and TNO155, including variants enriched in tumors.
- Open access
Moving in Leukemia, bioRxiv, Oncogene, Blood Cancer Discovery, Cell Reports, Molecular Cancer Therapeutics, Trends in Biochemical Sciences and British Journal of Pharmacology.
Rebuilt
Nothing in this topic has moved yet this week.
Newest first · last 60 days
AI summary · may contain errors
High-throughput base editor tiling in lung cancer cells identifies SHP2 gain-of-function mutations linked to resistance against migoprotafib and TNO155, including variants enriched in tumors.
AI summary · may contain errors
Intermittent dasatinib with a weekend holiday is noninferior to continuous 100 mg daily for major molecular remission at 24 months in first-line chronic phase chronic myeloid leukemia, with 81% vs 78%.
AI summary · may contain errors
In 29 patient-derived and established tumor spheroid models, pan-RAS(ON) daraxonrasib (RMC-6236) suppressed growth across diverse RAS alterations and wild-type RAS.
AI summary · may contain errors
Disease-causing mutations in full-length and catalytic-domain-only SHP-1 and SHP-2 alter WPD-loop dynamics, disrupting the active site and negatively impacting catalysis.
AI summary · may contain errors
Relcobatinib (ELVN-001) shows marked selectivity for BCR::ABL1 and robust anti-tumor activity in a human CML mouse xenograft model as monotherapy and with asciminib.
AI summary · may contain errors
In multiple myeloma cells, PP1C dephosphorylates KRAS/NRAS T148 to enable LZTR1-dependent proteasomal degradation, while KRAS A146 gain-of-function mutations resist this pathway.
AI summary · may contain errors
A posttranslational mechanism that regulates RAS stability is active almost exclusively in hematologic (heme) malignancies, highlighting a RAS hotspot mutation context in leukemia and myeloma.
AI summary · may contain errors
TS-BFS-BS reconstructs temporally continuous EGFR signaling routes through unmeasured bridge proteins from EGF time-course phosphoproteomics, retaining 94–99% of endpoints after removing measured hubs CBL and SRC.
AI summary · may contain errors
In a mouse myocardial infarction model, macrophage-specific PTPN2 knockdown diminishes gabapentin’s ability to reduce M1 polarization and cardiac dysfunction.
AI summary · may contain errors
CEBPA-mutant Hoxb8-FL multipotent murine progenitors transplanted into syngeneic mice progress to overt myeloid neoplasm in ~12 months with 100% penetrance and fatal outcome.
AI summary · may contain errors
Cryo-EM structures show how MAP2K MEK1 activates MAPK ERK2, revealing substrate-driven release of MEK1 catalytic machinery and specificity at the final cascade step.
AI summary · may contain errors
PADI1 and PADI3 expression is linked to worse prognosis in KRAS-mutant colorectal and pancreatic cancers, and PADI-dependent mitochondrial adaptation sustains resistance to KRAS inhibitors.
AI summary · may contain errors
In microsatellite stable colorectal cancer, tumor-intrinsic PTPN12 suppresses double-stranded RNA sensing and interferon signaling, enabling immune-refractory tumors.
AI summary · may contain errors
In Imatinib-resistant CML cells and CD34+ stem/progenitor cells, highly activated eIF4F—especially eIF4G1—supports BCR::ABL1 translation, and inhibiting eIF4G1 reduces BCR::ABL1 expression.
AI summary · may contain errors
KRAS inhibition with panRAS-ON or panKRAS-off remodels the KRAS interactome, altering 16.5% of KRAS-proximal proteins while producing highly correlated changes despite distinct inhibitor mechanisms.
AI summary · may contain errors
Cryo-EM structures show pMEK1 bound to unphosphorylated ERK1/2 and monophosphorylated ERK1 reveal how MEK1 enables dual phosphorylation and reverse dephosphorylation.
AI summary · may contain errors
c-Src recognition of KRAS4B-G12D is linked to nucleotide-dependent KRas switch dynamics, enabling access to phosphorylation sites Tyr32 (GTP) and Tyr64 (GDP).
AI summary · may contain errors
A subset of metabolic enzymes moonlights as protein kinases or phosphatases, directly linking glucose, fructose, lipid, nucleotide, and creatine metabolism to phosphorylation-dependent signaling.
AI summary · may contain errors
Daraxonrasib (RMC-6236) suppressed growth in patient-derived multi-cell type tumor spheroids across models with diverse RAS alterations and wild-type RAS, showing broad pan-RAS(ON) activity.
AI summary · may contain errors
Sustained deep molecular response enables treatment-free remission in chronic myeloid leukemia, with DMR duration linked more strongly to durable outcomes than rapid attainment in Japanese confirmatory studies.
AI summary · may contain errors
In Noonan syndrome models, cardiac fibroblast IL-8–CXCR1 signaling is linked to fibrosis-related signatures, tissue stiffness, and cardiomyocyte hypertrophy, and reparixin reverses these effects.
AI summary · may contain errors
PTP-centered interactome analyses show that nonreceptor and receptor protein tyrosine phosphatases act as scaffolds organizing spatial signaling complexes, linked to context-dependent outputs.
AI summary · may contain errors
MAPK14 (p38α) is a prominent, context-dependent dependency in gilteritinib-resistant FLT3-mutated acute myeloid leukemia cells, linked to sustained resistance.
AI summary · may contain errors
STAT1 is regulated by diverse post-translational modifications beyond phosphorylation, including vitamin C-derived vitcylation and pyruvate-induced pyruvylation, shaping its signaling outputs.
AI summary · may contain errors
Farnesylation drives cytoplasmic KRAS condensate formation, which promotes KRAS processing, trafficking, and signaling as a new mechanism for controlling RAS activity.
Journals this month
Topics moving, week to 20 Nov 2026
By field